Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Oligohydramnios
NCT02372487Unknown
- Sponsor
- Al Hayat National Hospital
- Start
- Mar 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Randomised, open-label trial of sildenafil in Oligohydramnios (Oligo) (2 arms), sponsored by Al Hayat National Hospital. Primary endpoint: Amniotic Fluid Index. Status: unknown.
02
Drugs
sildenafil
03
Conditions
Oligohydramnios (Oligo)
Beyond the preview
Go deeper on NCT02372487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02372487.